Stay updated with breaking news from Imaging core lab. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Minneapolis Heart Institute Foundation® (MHIF) today announced an important research milestone with the U.S. Food and Drug Administration (FDA) approval of the TriClip™ (manufactured by Abbott), a first-of-its-kind, non-surgical, transcatheter
Abbott has announced U.S Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 million people in the U.S. are estimated to be affected. Data from the TRILUMINATE Pivotal trial demonstrated that patients who received TriClip experienced a marked improvement in the severity of their symptoms and quality of life, with benefits sustained at one year.
Newark, CA (PRWEB) July 19, 2022 -- A study abstract published at the annual Society of Cardiac Computed Tomography (SCCT) congress last week indicated
Dublin, Feb. 03, 2022 (GLOBE NEWSWIRE) -- The "Clinical Trial Imaging Market Research Report by Product & Service, by Modality, by Therapeutic area,...
/PRNewswire/ -- The "Clinical Trial Imaging Market Research Report by Product & Service, by Modality, by Therapeutic area, by End-User, by Region - Global...